Globus Medical (GMED) Tops Q2 EPS by 4c, beats revenue

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $291.62 million versus the consensus estimate of $279.53 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• JPMorgan Upgrades YDUQS Participacoes SA (YDUQ3:BZ) to Overweight
• Kroger meets earnings expectations, revenue tops estimates